- Tytuł:
- Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet 3-9 June 2023 401(10391):1853-1865
Czasopismo naukowe